Procter & Gamble EPS Forecast Rises 2% to $1.57, Q2 Sales Seen at $20.6B
Procter & Gamble shares have climbed 12.1% over the past month, outperforming the S&P 500’s –1.5% and matching the Consumer Staples industry’s 12.8% gain. Analysts project Q2 EPS of $1.57 (+2% YoY) with sales of $20.62 billion (+4.3%), but consensus estimates have slipped 1% recently.
1. Recent Stock Performance
Procter & Gamble’s stock returned 12.1% over the past month, outpacing the S&P 500’s –1.5% change and aligning closely with the 12.8% gain in the Consumer Staples sector. This upward move reflects investor interest following solid quarterly results and upward revisions in revenue forecasts.
2. Earnings and Revenue Projections
For the current quarter, analysts expect EPS of $1.57, up 2% year-over-year, and consensus revenue of $20.62 billion, a 4.3% increase. However, EPS estimates have declined 1% over the last 30 days, while full-year EPS forecasts of $6.98 (+2.2%) and $7.28 (+4.3% next fiscal year) have each dipped slightly.
3. Valuation and Zacks Ranking
P&G holds a Zacks Rank of #4 (Sell) and a Value Style Score of D, indicating its shares trade at a premium relative to peers. Last quarter’s revenue of $22.21 billion (+1.5%) and EPS of $1.88 matched year-ago levels, with modest revenue and earnings surprises.